Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements Of Stockholders' Equity

v3.22.1
Condensed Consolidated Statements Of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Treasury Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Total
Balance at Dec. 31, 2020 $ 4 $ 513,979 $ (286,100) $ (23,789) $ 500 $ 204,594
Balance, shares at Dec. 31, 2020 35,198          
Balance, shares at Dec. 31, 2020       (3,970)    
Net income     5,677     5,677
Other comprehensive income (loss)         (120) (120)
Cash dividends ($0.025 per share)     (783)     (783)
Purchase of treasury stock       $ (651)   (651)
Purchase of treasury stock, shares       (41)    
Stock-based compensation expense   1,524       1,524
Proceeds from exercise of options   246       246
Proceeds from exercise of options, shares 127          
Balance at Mar. 31, 2021 $ 4 515,749 (281,206) $ (24,440) 380 210,487
Balance, shares at Mar. 31, 2021 35,325          
Balance, shares at Mar. 31, 2021       (4,011)    
Balance at Dec. 31, 2021 $ 4 662,996 (263,342) $ (24,440) (5,050) 370,168
Balance, shares at Dec. 31, 2021 41,105          
Balance, shares at Dec. 31, 2021       (4,011)    
Net income     5,309     5,309
Other comprehensive income (loss)         6,163 6,163
Cash dividends ($0.025 per share)     (930)     (930)
Purchase of treasury stock       $ (1,097)   (1,097)
Purchase of treasury stock, shares       (51)    
Stock-based compensation expense   3,367       3,367
Proceeds from exercise of options   126       126
Proceeds from exercise of options, shares 167          
Balance at Mar. 31, 2022 $ 4 $ 666,489 $ (258,963) $ (25,537) $ 1,113 $ 383,106
Balance, shares at Mar. 31, 2022 41,272          
Balance, shares at Mar. 31, 2022       (4,062)